Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
324.20
+5.37 (1.68%)
At close: May 1, 2026, 4:00 PM EDT
323.50
-0.70 (-0.22%)
After-hours: May 1, 2026, 7:45 PM EDT
PRAX Market Cap
PRAX has a market cap or net worth of $9.03 billion as of May 1, 2026. Its market cap has increased by 1,401.45% in one year.
Market Cap
9.03B
Enterprise Value
8.10B
1-Year Change
1,401.45%
Ranking
Category
Stock Price
$324.20
Market Cap Chart
Since the IPO on October 16, 2020, PRAX's market cap has increased from $698.02M to $9.03B, an increase of 1,193.54%. That is a compound annual growth rate of 58.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 9.03B | 22.50% |
| Dec 31, 2025 | 7.37B | 397.55% |
| Dec 31, 2024 | 1.48B | 675.84% |
| Dec 29, 2023 | 190.94M | 70.27% |
| Dec 30, 2022 | 112.14M | -87.31% |
| Dec 31, 2021 | 883.49M | -58.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exelixis | 11.10B |
| Axsome Therapeutics | 10.62B |
| Arrowhead Pharmaceuticals | 10.48B |
| BioMarin Pharmaceutical | 10.45B |
| ABIVAX Société Anonyme | 8.96B |
| Bio-Techne | 8.61B |
| Vaxcyte | 8.22B |
| Cytokinetics | 7.87B |